Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Nuocheng Bioproducts is a Chinese biotechnology company specializing in the research, development, and large-scale manufacturing of human vaccines. The company is most recognized for its production of the freeze-dried human rabies vaccine (Vero cell), which is a core product in the Chinese domestic market. Founded in 2006 and later becoming a subsidiary of Liaoning Cheng Da Biotechnology (Chengda Bio), the company operates advanced manufacturing facilities that comply with national GMP standards. Its business focus remains on infectious disease prevention through high-quality biological products and the expansion of its vaccine portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Nuocheng Bioproducts.